Up­dat­ed da­ta from a tri­al of John­son & John­son’s ex­per­i­men­tal “pret­zel” showed that more than 80% of blad­der ...

A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal ...

For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...

Pacific Biosciences is letting go of 190 employees, according to the company, as part of cost-cutting measures after ...

Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...

Sarepta Therapeutics’ chief scientist suggested that the FDA was ahead of schedule in reviewing the company’s application to ...

The new round of let­ters tar­gets 20 prod­ucts and fol­lows a push by the FTC last year to go af­ter patents on asth­ma ...

The Covid-era swag­ger is gone. The cost cuts are most­ly done. The ex­ec­u­tives are “cau­tious­ly op­ti­mistic.” And the ...

GSK wants to present Blenrep to regulatory bodies sooner. The UK pharma will submit Blenrep in second-line multiple myeloma ...

Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its ...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

Jang-Ho Cha had no interest in leaving his post at Novartis, where he led translational medicine for the pharma giant’s work ...